A novel CRISPR/Cas9 associated technology for sequence-specific nucleic acid enrichment.
Stevens RC, Steele JL, Glover WR, Sanchez-Garcia JF, Simpson SD, O'Rourke D, Ramsdell JS, MacManes MD, Thomas WK, Shuber AP.
Stevens RC, et al. Among authors: macmanes md.
PLoS One. 2019 Apr 18;14(4):e0215441. doi: 10.1371/journal.pone.0215441. eCollection 2019.
PLoS One. 2019.
PMID: 30998719
Free PMC article.